<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28712841</identifier>
<setSpec>1578-1968</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Villoria, R</dc:author>
<dc:author>Gomez-Esteban, J C</dc:author>
<dc:author>Molano, A</dc:author>
<dc:author>Acera, M</dc:author>
<dc:author>Tijero, B</dc:author>
<dc:author>Gabilondo, I</dc:author>
<dc:author>Lambarri, I</dc:author>
<dc:author>Somme, J</dc:author>
<dc:author>Ruiz de Gopegui, E</dc:author>
<dc:author>Bilbao, G</dc:author>
<dc:description xml:lang="en">OBJECTIVE The aim of this study was to evaluate the effects of deep brain stimulation of the subthalamic nucleus (DBS-SN) on cognitive function in patients with Parkinson's disease (PD) 5 years after surgery. MATERIAL AND METHODS We conducted a prospective study including 50 patients with PD who underwent DBS-SN (62.5% were men; mean age of 62.2±8.2 years; mean progression time of 14.1±6.3 years). All patients were assessed before the procedure and at one year after surgery; 40 patients were further followed up until the 5-year mark. Follow-up assessments included the following neuropsychological tests: Mini-Mental State Examination (MMSE), Mattis Dementia Rating Scale (MDRS), letter-number sequencing of the WAIS-III (WAIS-III-LN), clock-drawing test, Rey auditory verbal learning test (RAVLT), Benton Visual Retention Test (BVRT), Judgment of Line Orientation (JLO) test, FAS Phonemic Verbal Fluency Test, Stroop test, and the Montgomery-Asberg Depression Rating Scale (MADRS). RESULTS Patients were found to score lower on the MMSE (-0.89%), clock-drawing test (-2.61%), MDRS (-1.72%), and especially phonemic (-13.28%) and sematic verbal fluency tests (-12.40%) at one year after surgery. Delayed recall on the RAVLT worsened one year after the procedure (-10.12%). At 5 years, impairment affected mainly verbal fluency; scores decreased an additional 16.10% and 16.60% in semantic and phonemic verbal fluency, respectively. Moderate decreases were observed in immediate recall (-16.87%), WAIS-III-LN (-16.67%), and JLO test (-11.56%). DISCUSSION In our sample, DBS-SN did not result in global cognitive impairment 5 years after surgery. Verbal function was found to be significantly impaired one year after the procedure. Impaired learning and visuospatial function may be attributed to degeneration associated with PD.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Núcleo subtalámico</dc:subject>
<dc:subject>Enfermedad de Parkinson</dc:subject>
<dc:subject>Parkinson's disease</dc:subject>
<dc:subject>Deterioro cognitivo</dc:subject>
<dc:subject>Deep brain stimulation</dc:subject>
<dc:subject>Depresión</dc:subject>
<dc:subject>Depression</dc:subject>
<dc:subject>Estimulación cerebral profunda</dc:subject>
<dc:subject>Subthalamic nucleus</dc:subject>
<dc:subject>Calidad de vida</dc:subject>
<dc:subject>Cognitive impairment</dc:subject>
<dc:subject>Quality of life</dc:subject>
<dc:date>2017 Jul 13 </dc:date>
<dc:title xml:lang="es">Impacto de la estimulación subtalámica a largo plazo sobre la situación cognitiva de los pacientes con enfermedad de Parkinson avanzada.</dc:title>
<dc:title xml:lang="en">Long-term impact of subthalamic stimulation on cognitive function in patients with advanced Parkinson's disease.</dc:title>
<dc:publisher>Neurologia (Barcelona, Spain)</dc:publisher>
</metadata>
</record>
</pubmed-document>
